| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.43e-07 | 7 | 162 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.43e-07 | 7 | 162 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 8.44e-07 | 10 | 162 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 8.44e-07 | 10 | 162 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 8.44e-07 | 10 | 162 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.82e-06 | 13 | 162 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate binding | 5.31e-06 | 15 | 162 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 7.04e-06 | 16 | 162 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 7.04e-06 | 16 | 162 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.91e-05 | 24 | 162 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 6.33e-05 | 27 | 162 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 6.54e-05 | 2 | 162 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 6.54e-05 | 2 | 162 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 7.34e-05 | 28 | 162 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.80e-04 | 35 | 162 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.44e-04 | 69 | 162 | 5 | GO:0005504 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 2.72e-04 | 16 | 162 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 3.35e-04 | 41 | 162 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 6.44e-04 | 5 | 162 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.66e-04 | 49 | 162 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 7.62e-04 | 239 | 162 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.13e-03 | 254 | 162 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.34e-03 | 7 | 162 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.81e-03 | 107 | 162 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 1.99e-03 | 31 | 162 | 3 | GO:0004181 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.48e-03 | 115 | 162 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 2.61e-03 | 34 | 162 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipid binding | MAG CYP4F8 OPN4 CYP4A11 OBSCN DGKA DGKG APOB PICALM ACOX2 CYP4A22 PITPNM1 PIK3C2B PIK3C2G CYP4F12 SYT14P1 GOT2 | 2.82e-03 | 988 | 162 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 2.82e-03 | 10 | 162 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.84e-03 | 231 | 162 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ACAP1 OBSCN ARHGEF18 SIPA1 ARHGEF40 LLGL2 ARHGEF33 HPS4 AKAP13 SESN2 HERC1 | 2.91e-03 | 507 | 162 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ACAP1 OBSCN ARHGEF18 SIPA1 ARHGEF40 LLGL2 ARHGEF33 HPS4 AKAP13 SESN2 HERC1 | 2.91e-03 | 507 | 162 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 3.33e-03 | 37 | 162 | 3 | GO:0061631 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 3.43e-03 | 11 | 162 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 3.43e-03 | 11 | 162 | 2 | GO:0004143 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 3.45e-06 | 14 | 162 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 9.35e-06 | 6 | 162 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 1.63e-05 | 7 | 162 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 2.40e-05 | 22 | 162 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 2.59e-05 | 8 | 162 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 5.48e-05 | 10 | 162 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | metanephric ascending thin limb development | 6.13e-05 | 2 | 162 | 2 | GO:0072218 | |
| GeneOntologyBiologicalProcess | metanephric thick ascending limb development | 6.13e-05 | 2 | 162 | 2 | GO:0072233 | |
| GeneOntologyBiologicalProcess | ascending thin limb development | 6.13e-05 | 2 | 162 | 2 | GO:0072021 | |
| GeneOntologyBiologicalProcess | thick ascending limb development | 6.13e-05 | 2 | 162 | 2 | GO:0072023 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 7.49e-05 | 11 | 162 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 7.49e-05 | 11 | 162 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 9.93e-05 | 12 | 162 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.28e-04 | 13 | 162 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 1.83e-04 | 3 | 162 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.83e-04 | 3 | 162 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.90e-04 | 313 | 162 | 10 | GO:0098742 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.96e-04 | 68 | 162 | 5 | GO:0019369 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | GPLD1 ACAP1 CYP4F8 CYP4A11 APOB PLBD2 ACOX2 LIPA SESN2 CYP4F12 ACOT2 | 2.25e-04 | 382 | 162 | 11 | GO:0016042 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.47e-04 | 16 | 162 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | presynapse organization | 2.74e-04 | 73 | 162 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 2.77e-04 | 268 | 162 | 9 | GO:0045017 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 3.26e-04 | 217 | 162 | 8 | GO:0046474 | |
| GeneOntologyBiologicalProcess | metanephric loop of Henle development | 3.64e-04 | 4 | 162 | 2 | GO:0072236 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.64e-04 | 4 | 162 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | regulation of terminal button organization | 3.64e-04 | 4 | 162 | 2 | GO:2000331 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 4.45e-04 | 124 | 162 | 6 | GO:0001676 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.78e-06 | 4 | 161 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | symmetric synapse | 1.21e-04 | 13 | 161 | 3 | GO:0032280 | |
| Domain | - | EML6 APAF1 TEP1 DCAF12L2 BIRC6 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 PAN2 HERC1 WDR17 PLRG1 | 3.78e-08 | 333 | 163 | 16 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | EML6 APAF1 TEP1 DCAF12L2 BIRC6 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 PAN2 HERC1 WDR17 PLRG1 | 4.11e-08 | 335 | 163 | 16 | IPR015943 |
| Domain | WD40_repeat_dom | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 PAN2 HERC1 WDR17 PLRG1 | 5.37e-08 | 297 | 163 | 15 | IPR017986 |
| Domain | WD40 | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 6.58e-08 | 259 | 163 | 14 | PF00400 |
| Domain | WD40 | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.00e-07 | 268 | 163 | 14 | SM00320 |
| Domain | WD40_repeat | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.21e-07 | 272 | 163 | 14 | IPR001680 |
| Domain | WD_REPEATS_1 | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.58e-07 | 278 | 163 | 14 | PS00678 |
| Domain | WD_REPEATS_2 | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.65e-07 | 279 | 163 | 14 | PS50082 |
| Domain | WD_REPEATS_REGION | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.65e-07 | 279 | 163 | 14 | PS50294 |
| Domain | WD40_repeat_CS | EML6 APAF1 TEP1 WDFY4 WDFY2 AAAS UTP18 LLGL2 HERC1 WDR17 PLRG1 | 2.07e-07 | 164 | 163 | 11 | IPR019775 |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.59e-06 | 4 | 163 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.59e-06 | 4 | 163 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.59e-06 | 4 | 163 | 3 | IPR015753 | |
| Domain | Nlgn | 6.44e-06 | 5 | 163 | 3 | IPR000460 | |
| Domain | NLGN4 | 7.57e-05 | 2 | 163 | 2 | IPR030025 | |
| Domain | CYTOCHROME_P450 | 1.38e-04 | 57 | 163 | 5 | PS00086 | |
| Domain | - | 1.50e-04 | 58 | 163 | 5 | 1.10.630.10 | |
| Domain | p450 | 1.50e-04 | 58 | 163 | 5 | PF00067 | |
| Domain | Carboxylesterase_B_CS | 1.75e-04 | 13 | 163 | 3 | IPR019819 | |
| Domain | Cyt_P450 | 1.77e-04 | 60 | 163 | 5 | IPR001128 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.21e-04 | 14 | 163 | 3 | PS00941 | |
| Domain | COesterase | 2.21e-04 | 14 | 163 | 3 | PF00135 | |
| Domain | CarbesteraseB | 2.21e-04 | 14 | 163 | 3 | IPR002018 | |
| Domain | - | 2.26e-04 | 3 | 163 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 2.26e-04 | 3 | 163 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 2.26e-04 | 3 | 163 | 2 | IPR029477 | |
| Domain | - | 3.37e-04 | 248 | 163 | 9 | 1.25.40.20 | |
| Domain | RhoGEF | 3.65e-04 | 70 | 163 | 5 | PF00621 | |
| Domain | DH_2 | 3.65e-04 | 70 | 163 | 5 | PS50010 | |
| Domain | - | 3.90e-04 | 71 | 163 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 3.90e-04 | 71 | 163 | 5 | IPR000219 | |
| Domain | Ankyrin_rpt-contain_dom | 4.01e-04 | 254 | 163 | 9 | IPR020683 | |
| Domain | Ankyrin_rpt | 5.02e-04 | 262 | 163 | 9 | IPR002110 | |
| Domain | Ank_2 | 6.12e-04 | 215 | 163 | 8 | PF12796 | |
| Domain | Cyt_P450_E_grp-I | 6.30e-04 | 45 | 163 | 4 | IPR002401 | |
| Domain | Ank | 8.96e-04 | 228 | 163 | 8 | PF00023 | |
| Domain | Cyt_P450_CS | 1.17e-03 | 53 | 163 | 4 | IPR017972 | |
| Domain | PI3K_Ras-bd_dom | 1.54e-03 | 7 | 163 | 2 | IPR000341 | |
| Domain | PI3K_rbd | 1.54e-03 | 7 | 163 | 2 | SM00144 | |
| Domain | E-NPP | 1.54e-03 | 7 | 163 | 2 | IPR024873 | |
| Domain | PI3K_rbd | 1.54e-03 | 7 | 163 | 2 | PF00794 | |
| Domain | PI3K_RBD | 1.54e-03 | 7 | 163 | 2 | PS51546 | |
| Domain | ANK | 1.65e-03 | 251 | 163 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 1.74e-03 | 253 | 163 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 1.78e-03 | 254 | 163 | 8 | PS50297 | |
| Domain | PI3K_C2 | 2.05e-03 | 8 | 163 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 2.05e-03 | 8 | 163 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 2.05e-03 | 8 | 163 | 2 | PF00792 | |
| Domain | PI3K_C2 | 2.05e-03 | 8 | 163 | 2 | PS51547 | |
| Domain | DH_1 | 2.23e-03 | 63 | 163 | 4 | PS00741 | |
| Domain | PI3Ka | 2.62e-03 | 9 | 163 | 2 | PF00613 | |
| Domain | PI3Ka | 2.62e-03 | 9 | 163 | 2 | SM00145 | |
| Domain | - | 2.62e-03 | 9 | 163 | 2 | 1.25.40.70 | |
| Domain | RhoGEF | 2.95e-03 | 68 | 163 | 4 | SM00325 | |
| Domain | RNaseH-like_dom | 3.11e-03 | 69 | 163 | 4 | IPR012337 | |
| Domain | DAGK_acc | 3.25e-03 | 10 | 163 | 2 | PF00609 | |
| Domain | ThiF_NAD_FAD-bd | 3.25e-03 | 10 | 163 | 2 | IPR000594 | |
| Domain | Diacylglycerol_kin_accessory | 3.25e-03 | 10 | 163 | 2 | IPR000756 | |
| Domain | ThiF | 3.25e-03 | 10 | 163 | 2 | PF00899 | |
| Domain | PI_Kinase | 3.25e-03 | 10 | 163 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 3.25e-03 | 10 | 163 | 2 | IPR001263 | |
| Domain | Phosphodiest/P_Trfase | 3.25e-03 | 10 | 163 | 2 | IPR002591 | |
| Domain | Cyt_P450_E_grp-IV | 3.25e-03 | 10 | 163 | 2 | IPR002403 | |
| Domain | Phosphodiest | 3.25e-03 | 10 | 163 | 2 | PF01663 | |
| Domain | PIK_HELICAL | 3.25e-03 | 10 | 163 | 2 | PS51545 | |
| Domain | DAGKa | 3.25e-03 | 10 | 163 | 2 | SM00045 | |
| Domain | - | 3.91e-03 | 119 | 163 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.91e-03 | 119 | 163 | 5 | IPR029058 | |
| Domain | GFP-like | 3.95e-03 | 11 | 163 | 2 | IPR023413 | |
| Domain | - | 3.95e-03 | 11 | 163 | 2 | 2.40.155.10 | |
| Domain | EGF_dom | 4.72e-03 | 12 | 163 | 2 | IPR024731 | |
| Domain | EGF_3 | 4.72e-03 | 12 | 163 | 2 | PF12947 | |
| Domain | UQ_con | 4.74e-03 | 39 | 163 | 3 | PF00179 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 5.09e-03 | 40 | 163 | 3 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 5.46e-03 | 41 | 163 | 3 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 5.46e-03 | 41 | 163 | 3 | IPR000608 | |
| Domain | CarboxyPept_regulatory_dom | 5.54e-03 | 13 | 163 | 2 | IPR014766 | |
| Domain | - | 5.54e-03 | 13 | 163 | 2 | 2.60.40.1120 | |
| Domain | Dynein_HC_stalk | 6.43e-03 | 14 | 163 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.43e-03 | 14 | 163 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.43e-03 | 14 | 163 | 2 | PF08393 | |
| Domain | PLAC | 6.43e-03 | 14 | 163 | 2 | PF08686 | |
| Domain | MT | 6.43e-03 | 14 | 163 | 2 | PF12777 | |
| Domain | DAGKc | 6.43e-03 | 14 | 163 | 2 | SM00046 | |
| Domain | G-protein_beta_WD-40_rep | 6.55e-03 | 85 | 163 | 4 | IPR020472 | |
| Domain | DHC_fam | 7.38e-03 | 15 | 163 | 2 | IPR026983 | |
| Domain | Diacylglycerol_kinase_cat_dom | 7.38e-03 | 15 | 163 | 2 | IPR001206 | |
| Domain | DAGK | 7.38e-03 | 15 | 163 | 2 | PS50146 | |
| Domain | Dynein_heavy | 7.38e-03 | 15 | 163 | 2 | PF03028 | |
| Domain | PI3/4_kinase_CS | 7.38e-03 | 15 | 163 | 2 | IPR018936 | |
| Domain | N2O_reductase_N | 7.38e-03 | 15 | 163 | 2 | IPR011045 | |
| Domain | DAGK_cat | 7.38e-03 | 15 | 163 | 2 | PF00781 | |
| Domain | Dynein_heavy_dom | 7.38e-03 | 15 | 163 | 2 | IPR004273 | |
| Domain | - | 7.99e-03 | 47 | 163 | 3 | 3.30.420.10 | |
| Domain | Kinase-like_dom | OBSCN CHD9 ALPK1 MAST2 MKNK1 NUAK2 RNASEL PIK3C2B PIK3C2G MAPK7 MAP3K7 | 8.12e-03 | 542 | 163 | 11 | IPR011009 |
| Domain | - | 8.38e-03 | 16 | 163 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 8.38e-03 | 16 | 163 | 2 | SM00146 | |
| Pathway | REACTOME_EICOSANOIDS | 3.66e-08 | 12 | 124 | 5 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 3.66e-08 | 12 | 124 | 5 | MM14845 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 5.33e-06 | 14 | 124 | 4 | MM15842 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 6.87e-06 | 31 | 124 | 5 | M39851 | |
| Pathway | REACTOME_FATTY_ACIDS | 7.22e-06 | 15 | 124 | 4 | M27126 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | MAG OBSCN ARHGEF18 MIB2 ARHGEF40 UBE2D1 ARHGEF33 AKAP13 MAP3K7 | 8.54e-06 | 154 | 124 | 9 | M27697 |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 9.46e-06 | 33 | 124 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 9.46e-06 | 33 | 124 | 5 | MM15963 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.59e-05 | 18 | 124 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.59e-05 | 18 | 124 | 4 | MM14841 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 3.58e-05 | 142 | 124 | 8 | MM15431 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 5.37e-05 | 9 | 124 | 3 | M39819 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.25e-05 | 25 | 124 | 4 | MM14858 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.04e-04 | 11 | 124 | 3 | MM14863 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 1.14e-04 | 29 | 124 | 4 | M39858 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.66e-04 | 59 | 124 | 5 | M11215 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.95e-04 | 61 | 124 | 5 | MM14861 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.11e-04 | 97 | 124 | 6 | M9400 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.45e-04 | 64 | 124 | 5 | M5650 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 2.67e-04 | 143 | 124 | 7 | M39591 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.83e-04 | 66 | 124 | 5 | MM14839 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.45e-04 | 76 | 124 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 6.89e-04 | 80 | 124 | 5 | M800 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.56e-04 | 170 | 124 | 7 | MM15573 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 7.87e-04 | 21 | 124 | 3 | M27137 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 9.09e-04 | 85 | 124 | 5 | MM14746 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 TRPM4 NLGN4Y SDCCAG8 OBSCN PEPD ARHGEF18 CHD9 CPD IQCN TNRC6C TEP1 PLBD2 NPLOC4 SHKBP1 NLGN3 EXD3 SMG7 UBAP2L PVR ANKRD11 CCAR1 ENPP5 AKAP13 RAI1 | 5.24e-08 | 1489 | 167 | 25 | 28611215 |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 32011705 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 18628683 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 22419166 | ||
| Pubmed | TCF-1 negatively regulates the suppressive ability of canonical and noncanonical Tregs. | 4.33e-07 | 4 | 167 | 3 | 36806938 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 4.33e-07 | 4 | 167 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 4.33e-07 | 4 | 167 | 3 | 22671294 | |
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 20579107 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 16077734 | ||
| Pubmed | 4.33e-07 | 4 | 167 | 3 | 17292328 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | UBA5 LRRC37A3 TAF1A APAF1 CHD9 PFAS CPD MIB2 IQCN PICALM EMSY SHKBP1 PITPNM1 UBE2D1 TAMM41 UBE2D4 P2RY2 MAPK7 | 5.66e-07 | 925 | 167 | 18 | 28986522 |
| Pubmed | VTN TTC28 DGKA PFAS MIB2 CLSTN1 MAST2 NPLOC4 ARHGEF40 LLGL2 WDR6 NOM1 CCAR1 AKAP13 PLRG1 | 6.48e-07 | 650 | 167 | 15 | 38777146 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | UBA5 NCOA3 ANKS6 ROGDI ALPK1 TNRC6C PICALM TRIP4 MKNK1 SHKBP1 AAAS UTP18 SMG7 PIK3C2B UBAP2L TMED8 MAPK7 MAP3K7 PLRG1 | 6.75e-07 | 1038 | 167 | 19 | 26673895 |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.08e-06 | 5 | 167 | 3 | 10996085 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 ANKS6 SPG7 OBSCN PFAS MIB2 TNRC6C TEP1 MAST2 BIRC6 FAT1 ARHGEF40 LLGL2 DNAJC14 PIK3C2B ANKRD11 AKAP13 HERC1 RAI1 | 1.70e-06 | 1105 | 167 | 19 | 35748872 |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 21838267 | ||
| Pubmed | CD4+ T cell immunity is dependent on an intrinsic stem-like program. | 2.15e-06 | 6 | 167 | 3 | 38168955 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 29724786 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 2.24e-06 | 44 | 167 | 5 | 12745259 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 5.98e-06 | 8 | 167 | 3 | 30871858 | |
| Pubmed | PFAS MIB2 BIRC6 TRIP4 PLBD2 NPLOC4 SHKBP1 UBE2D1 PIK3C2B WDR6 GLG1 HERC1 MAP3K7 | 7.85e-06 | 604 | 167 | 13 | 38803224 | |
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 23010509 | ||
| Pubmed | 1.06e-05 | 285 | 167 | 9 | 34369648 | ||
| Pubmed | 1.27e-05 | 10 | 167 | 3 | 23064749 | ||
| Pubmed | 1.42e-05 | 225 | 167 | 8 | 12168954 | ||
| Pubmed | 1.74e-05 | 11 | 167 | 3 | 32973045 | ||
| Pubmed | 1.74e-05 | 11 | 167 | 3 | 26403076 | ||
| Pubmed | 1.83e-05 | 233 | 167 | 8 | 37704626 | ||
| Pubmed | 1.88e-05 | 234 | 167 | 8 | 36243803 | ||
| Pubmed | 2.26e-05 | 70 | 167 | 5 | 15128046 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15611369 | ||
| Pubmed | Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. | 2.29e-05 | 2 | 167 | 2 | 21307296 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 27782075 | ||
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 2.29e-05 | 2 | 167 | 2 | 28948087 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24823810 | ||
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 2.29e-05 | 2 | 167 | 2 | 16648374 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 2.29e-05 | 2 | 167 | 2 | 19645625 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16204645 | ||
| Pubmed | Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. | 2.29e-05 | 2 | 167 | 2 | 16273099 | |
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 2.29e-05 | 2 | 167 | 2 | 15274046 | |
| Pubmed | T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells. | 2.29e-05 | 2 | 167 | 2 | 34630413 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 20935204 | ||
| Pubmed | Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. | 2.29e-05 | 2 | 167 | 2 | 23197535 | |
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.29e-05 | 2 | 167 | 2 | 23641057 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 30709927 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23183221 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24855039 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28924369 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 28912346 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 2.29e-05 | 2 | 167 | 2 | 37001827 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24413902 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 11437656 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17360660 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8031839 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 10860550 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 30246373 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26762769 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 24495857 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 2.29e-05 | 2 | 167 | 2 | 11320253 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18189281 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 36756120 | ||
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 2.29e-05 | 2 | 167 | 2 | 12464262 | |
| Pubmed | T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1. | 2.29e-05 | 2 | 167 | 2 | 29424438 | |
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 2.29e-05 | 2 | 167 | 2 | 15066132 | |
| Pubmed | Disorder-associated mutations lead to functional inactivation of neuroligins. | 2.29e-05 | 2 | 167 | 2 | 15150161 | |
| Pubmed | Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. | 2.29e-05 | 2 | 167 | 2 | 15622415 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 35803063 | ||
| Pubmed | Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells. | 2.29e-05 | 2 | 167 | 2 | 17312115 | |
| Pubmed | Control of effector CD8+ T cell function by the transcription factor Eomesodermin. | 2.29e-05 | 2 | 167 | 2 | 14605368 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 23825080 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16691295 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 3829886 | ||
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 2.29e-05 | 2 | 167 | 2 | 29277328 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 18434543 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21820496 | ||
| Pubmed | Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells. | 2.29e-05 | 2 | 167 | 2 | 32991634 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26438526 | ||
| Pubmed | Differential localization of T-bet and Eomes in CD8 T cell memory populations. | 2.29e-05 | 2 | 167 | 2 | 23455505 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16112640 | ||
| Pubmed | Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. | 2.29e-05 | 2 | 167 | 2 | 23431752 | |
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 2.29e-05 | 2 | 167 | 2 | 20943934 | |
| Pubmed | Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. | 2.29e-05 | 2 | 167 | 2 | 31788936 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 25032686 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 2.29e-05 | 2 | 167 | 2 | 37080762 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 2766933 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 16508939 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22490682 | ||
| Pubmed | T-BET and EOMES sustain mature human NK cell identity and antitumor function. | 2.29e-05 | 2 | 167 | 2 | 37279078 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 29106499 | ||
| Pubmed | NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. | 2.29e-05 | 2 | 167 | 2 | 15389766 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 2.29e-05 | 2 | 167 | 2 | 24104404 | |
| Pubmed | Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza. | 2.29e-05 | 2 | 167 | 2 | 35338093 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 2.29e-05 | 2 | 167 | 2 | 32243781 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 22989184 | ||
| Pubmed | Eomesodermin and T-bet mark developmentally distinct human natural killer cells. | 2.29e-05 | 2 | 167 | 2 | 28289707 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 17112342 | ||
| Pubmed | The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. | 2.29e-05 | 2 | 167 | 2 | 22261438 | |
| Pubmed | Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. | 2.29e-05 | 2 | 167 | 2 | 24570023 | |
| GeneFamily | WD repeat domain containing | EML6 APAF1 TEP1 DCAF12L2 WDFY4 WDFY2 SHKBP1 AAAS UTP18 LLGL2 WDR6 HERC1 WDR17 PLRG1 | 1.09e-09 | 262 | 114 | 14 | 362 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.00e-05 | 66 | 114 | 5 | 722 | |
| GeneFamily | Cytochrome P450 family 4 | 7.56e-05 | 36 | 114 | 4 | 1003 | |
| GeneFamily | Ankyrin repeat domain containing | 1.49e-04 | 242 | 114 | 8 | 403 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.08e-03 | 8 | 114 | 2 | 831 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.72e-03 | 10 | 114 | 2 | 1178 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.72e-03 | 10 | 114 | 2 | 100 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 2.19e-03 | 41 | 114 | 3 | 102 | |
| GeneFamily | Fibronectin type III domain containing | 3.45e-03 | 160 | 114 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.54e-03 | 161 | 114 | 5 | 593 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.92e-03 | 15 | 114 | 2 | 26 | |
| GeneFamily | Cadherin related | 5.04e-03 | 17 | 114 | 2 | 24 | |
| GeneFamily | T-boxes | 5.64e-03 | 18 | 114 | 2 | 766 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SPG7 SUSD6 DGKA IQCN CLSTN1 CXXC1 WDFY2 MKNK1 NUAK2 PITPNM1 UBA7 WDR6 HPS4 ANKRD11 PAN2 AKAP13 OTULINL SRRM2 RAI1 | 5.03e-06 | 905 | 166 | 19 | M40865 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | TSNAXIP1 NCOA3 SUSD6 APAF1 DGKA TCTA CPD PICALM UBE2D1 SMG7 UBE2D4 UBAP2L WDR6 SESN2 ACOT2 PLG HERC1 SRRM2 GOT2 | 2.81e-05 | 1024 | 166 | 19 | M1742 |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP | 4.30e-05 | 200 | 166 | 8 | M9324 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN | 4.30e-05 | 200 | 166 | 8 | M3877 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 4.30e-05 | 200 | 166 | 8 | M6004 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 4.30e-05 | 200 | 166 | 8 | M7441 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 4.30e-05 | 200 | 166 | 8 | M6563 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-07 | 179 | 167 | 8 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-07 | 179 | 167 | 8 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-07 | 179 | 167 | 8 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 161 | 167 | 7 | ae1cee34361dde9964581cca99a29578c3b3bd99 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 161 | 167 | 7 | 33de3e8b3238fcfc66dfbf89a913a07d464d6c35 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 172 | 167 | 7 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-06 | 184 | 167 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-06 | 184 | 167 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.23e-06 | 184 | 167 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.92e-06 | 187 | 167 | 7 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK|ICU-NoSEP / Disease, Lineage and Cell Type | 8.80e-06 | 194 | 167 | 7 | 090edfc884655e5ab38b027c6e1a5aa809ebb19d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK|ICU-NoSEP / Disease, condition lineage and cell class | 1.07e-05 | 200 | 167 | 7 | 6d1e927c4498dc8a6152c211d414f719d9c1f436 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_CD56bright|COVID-19_Severe / Disease, condition lineage and cell class | 1.07e-05 | 200 | 167 | 7 | 12626d046a3ed8db1c9bd603ada5b97ead93e587 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 154 | 167 | 6 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 157 | 167 | 6 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 3.39e-05 | 162 | 167 | 6 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 163 | 167 | 6 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-05 | 99 | 167 | 5 | a815a887094204de30b299e8907e81ad9a39c016 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 164 | 167 | 6 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 164 | 167 | 6 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 164 | 167 | 6 | 7a51365bad2910c130bd952805f7a1bef51be481 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 164 | 167 | 6 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.88e-05 | 166 | 167 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-05 | 167 | 167 | 6 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 167 | 167 | 6 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 168 | 167 | 6 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | Immune_cells-NK_cells|Immune_cells / Lineage and Cell class | 4.15e-05 | 168 | 167 | 6 | 125d70c37eb49eb4d1f503bb8d536b225254c7cb | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 169 | 167 | 6 | 573f85075d83a4baba41c3e24dc4d9831823a5e5 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 169 | 167 | 6 | a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 170 | 167 | 6 | 26178277bf9c7f2f06b5c0b03d4b69d78e9580c4 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 4.43e-05 | 170 | 167 | 6 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.89e-05 | 173 | 167 | 6 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | facs-Heart-LA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | 30c083fe4711735e83dccfd00fcd746ae673d353 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | 46d19c1144fff19be682b7ba59d4c3e014f79e15 | |
| ToppCell | facs-Heart-LA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 174 | 167 | 6 | 1802a52552256d1e25d8b328ba62dcfe41671900 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 175 | 167 | 6 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 176 | 167 | 6 | a23d484aff5ad094333b2feae9106ca219514711 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.55e-05 | 177 | 167 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-05 | 177 | 167 | 6 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-05 | 177 | 167 | 6 | d6b7d387e7485ff52ce27f51df8b8050f49fd941 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-05 | 179 | 167 | 6 | 5ccf0824611ded5c673d94dff3048aedac12f1a8 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 5.91e-05 | 179 | 167 | 6 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 167 | 6 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-05 | 183 | 167 | 6 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.88e-05 | 184 | 167 | 6 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-05 | 185 | 167 | 6 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-05 | 185 | 167 | 6 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.09e-05 | 185 | 167 | 6 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | f14722ecc832794dc267bf3f9b8a13274c3addc1 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-05 | 186 | 167 | 6 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-05 | 187 | 167 | 6 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.45e-05 | 191 | 167 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.70e-05 | 192 | 167 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 192 | 167 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | Mild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.95e-05 | 193 | 167 | 6 | 9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 8.95e-05 | 193 | 167 | 6 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 195 | 167 | 6 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.47e-05 | 195 | 167 | 6 | 234666fb7a1fd7e33bb7e54fd4004649ce22de70 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.47e-05 | 195 | 167 | 6 | f0fb039f3d2e36acb258afb8b6d2fed20c395c36 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.47e-05 | 195 | 167 | 6 | c7743d8c57584d29cca69c6405f1df6718174582 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.74e-05 | 196 | 167 | 6 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.74e-05 | 196 | 167 | 6 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.74e-05 | 196 | 167 | 6 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 198 | 167 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.03e-04 | 198 | 167 | 6 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.06e-04 | 199 | 167 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 200 | 167 | 6 | 1dd0141e87902d96a76edcd966988f61a532c808 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-04 | 200 | 167 | 6 | 7f79ab7737188b1f7fb5c2a0b1d6d2a565d36385 | |
| ToppCell | Control-Lymphoid_T/NK|Control / Disease group, lineage and cell class | 1.09e-04 | 200 | 167 | 6 | b5d5eead192a22c6b5ea699fe36873809fe6e3e2 | |
| ToppCell | Control-Control-Lymphocyte-T/NK|Control / Disease, condition lineage and cell class | 1.09e-04 | 200 | 167 | 6 | 6a399d9fa005547e5fadd3c0dafd7e4381732460 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 1.09e-04 | 200 | 167 | 6 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 200 | 167 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 200 | 167 | 6 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 128 | 167 | 5 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 135 | 167 | 5 | 7b456fa9a5f5ce58976a8f1fad18c0f96a096930 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 136 | 167 | 5 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 136 | 167 | 5 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| Drug | (Z)-7-[(1S,4R,6R)-5-[(E)-oct-1-enyl]-2,3-diazabicyclo[2.2.1]hept-2-en-6-yl]hept-5-enoic acid | 5.53e-07 | 10 | 166 | 4 | CID009905657 | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.02e-06 | 198 | 166 | 10 | 3681_DN | |
| Drug | Sparteinum | 9.34e-06 | 101 | 166 | 7 | CID000003966 | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.32e-05 | 194 | 166 | 9 | 2467_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 7251_UP | |
| Drug | PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 7076_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; PC3; HT_HG-U133A | GPLD1 SF3A1 GDAP1 GPR135 ADAMTSL3 PTGIS ARHGEF40 UBA7 OTULINL | 1.61e-05 | 199 | 166 | 9 | 5879_UP |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 5756_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 1.61e-05 | 199 | 166 | 9 | 1383_UP | |
| Disease | Cystic Kidney Diseases | 2.55e-05 | 11 | 161 | 3 | C1691228 | |
| Disease | ectonucleotide pyrophosphatase/phosphodiesterase family member 5 measurement | 8.84e-05 | 3 | 161 | 2 | EFO_0801560 | |
| Disease | Autism Spectrum Disorders | 1.05e-04 | 85 | 161 | 5 | C1510586 | |
| Disease | dodecenedioate (C12:1-DC) measurement | 1.76e-04 | 4 | 161 | 2 | EFO_0800561 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.36e-04 | 101 | 161 | 5 | EFO_0004530, EFO_0007878 | |
| Disease | obesity | 3.73e-04 | 241 | 161 | 7 | EFO_0001073 | |
| Disease | torsin-1A-interacting protein 1 measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0802137 | |
| Disease | X-14939 measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0800747 | |
| Disease | Cystic kidney | 4.37e-04 | 6 | 161 | 2 | C0022679 | |
| Disease | systemic lupus erythematosus | PRSS54 IL12RB2 ACAP1 CYP4F8 TCF7 CHD9 IQCN SIPA1 WDFY4 ACOX2 SMG7 C1QTNF12 CX3CL1 | 4.62e-04 | 799 | 161 | 13 | MONDO_0007915 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 4.80e-04 | 330 | 161 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | Colorectal Carcinoma | ACAP1 SF3A1 OBSCN APOB ADAMTSL3 F5 FAT1 NLGN4X NPAP1 PAN2 CCAR1 SESN2 | 4.97e-04 | 702 | 161 | 12 | C0009402 |
| Disease | Prostatic Neoplasms | NAT2 NCOA3 TRPM4 ETV5 AAAS RNASEL PVR ENPP5 AKAP13 MAP3K7 CX3CL1 | 5.96e-04 | 616 | 161 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | NAT2 NCOA3 TRPM4 ETV5 AAAS RNASEL PVR ENPP5 AKAP13 MAP3K7 CX3CL1 | 5.96e-04 | 616 | 161 | 11 | C0376358 |
| Disease | 10-undecenoate 11:1n1 measurement | 6.10e-04 | 7 | 161 | 2 | EFO_0021099 | |
| Disease | X-18899 measurement | 6.10e-04 | 7 | 161 | 2 | EFO_0800793 | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 8.11e-04 | 8 | 161 | 2 | EFO_0801556 | |
| Disease | eosinophil percentage of leukocytes | TCF7 SF3A1 ARHGEF18 C16orf96 CLSTN1 EMSY EOMES PIK3C2B AKAP13 SESN2 OTULINL CX3CL1 | 8.44e-04 | 746 | 161 | 12 | EFO_0007991 |
| Disease | Calcium channel blocker use measurement | 1.15e-03 | 213 | 161 | 6 | EFO_0009930 | |
| Disease | eosinophil count | GPLD1 TCF7 SF3A1 TBX21 ARHGEF18 C16orf96 CLSTN1 EMSY EOMES PIK3C2B WDR6 TMED8 ANKRD11 AKAP13 SESN2 OTULINL CX3CL1 RAI1 | 1.32e-03 | 1488 | 161 | 18 | EFO_0004842 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.36e-03 | 40 | 161 | 3 | EFO_0004746 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.42e-03 | 222 | 161 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.58e-03 | 11 | 161 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.58e-03 | 11 | 161 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | X-21607 measurement | 1.58e-03 | 11 | 161 | 2 | EFO_0800819 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.68e-03 | 43 | 161 | 3 | EFO_0022290 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.78e-03 | 315 | 161 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.85e-03 | 95 | 161 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | hair colour measurement, hair morphology measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | temporal arteritis | 1.88e-03 | 12 | 161 | 2 | EFO_1001209 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.92e-03 | 96 | 161 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.98e-03 | 321 | 161 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.06e-03 | 239 | 161 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | Ischemic stroke | 2.08e-03 | 324 | 161 | 7 | HP_0002140 | |
| Disease | triglyceride measurement, alcohol drinking | 2.15e-03 | 99 | 161 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 2.22e-03 | 13 | 161 | 2 | EFO_0800588 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.22e-03 | 13 | 161 | 2 | EFO_0802114 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.24e-03 | 243 | 161 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | Malignant neoplasm of breast | ANKRD29 EPOR NAT2 NCOA3 ACAP1 PIGS LRRC37A2 OBSCN DGKG EMSY EOMES LLGL2 LRRC37A ZNF646 | 2.34e-03 | 1074 | 161 | 14 | C0006142 |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.59e-03 | 50 | 161 | 3 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.74e-03 | 51 | 161 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.74e-03 | 51 | 161 | 3 | EFO_0022240 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.75e-03 | 106 | 161 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | thrombosis (is_implicated_in) | 2.97e-03 | 15 | 161 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | waist-hip ratio | PRUNE2 TTC28 SDCCAG8 PEPD DGKG IQCN SIPA1 ADAMTSL3 DCAF12L2 BIRC6 PTGIS STAB1 UTP18 PIK3C2B SP6 | 3.00e-03 | 1226 | 161 | 15 | EFO_0004343 |
| Disease | fibrinogen measurement | 3.05e-03 | 109 | 161 | 4 | EFO_0004623 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.05e-03 | 109 | 161 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides in HDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 3.06e-03 | 53 | 161 | 3 | EFO_0022286 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.15e-03 | 110 | 161 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.15e-03 | 110 | 161 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.15e-03 | 110 | 161 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides in medium HDL measurement | 3.23e-03 | 54 | 161 | 3 | EFO_0022321 | |
| Disease | creatinine measurement | SDCCAG8 OBSCN ETV5 ARHGEF18 CHD9 NEB MAST2 BIRC6 NPLOC4 LFNG SP6 ANKRD11 UMOD | 3.27e-03 | 995 | 161 | 13 | EFO_0004518 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.37e-03 | 264 | 161 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | triglycerides in LDL measurement | 3.58e-03 | 56 | 161 | 3 | EFO_0022320 | |
| Disease | physical activity measurement, body mass index | 3.58e-03 | 114 | 161 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | serum non-albumin protein measurement | 3.79e-03 | 361 | 161 | 7 | EFO_0004568 | |
| Disease | Alzheimer disease, psychotic symptoms | 3.81e-03 | 17 | 161 | 2 | EFO_0005940, MONDO_0004975 | |
| Disease | low density lipoprotein particle size measurement | 3.95e-03 | 58 | 161 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.14e-03 | 59 | 161 | 3 | EFO_0022337 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.27e-03 | 18 | 161 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.34e-03 | 60 | 161 | 3 | C4722327 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 4.55e-03 | 122 | 161 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | Phenyllactate (PLA) measurement | 4.76e-03 | 19 | 161 | 2 | EFO_0021662 | |
| Disease | phospholipids in large VLDL measurement | 4.76e-03 | 62 | 161 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 4.76e-03 | 62 | 161 | 3 | EFO_0022322 | |
| Disease | hypothyroidism | 4.80e-03 | 284 | 161 | 6 | EFO_0004705 | |
| Disease | metabolic syndrome | 4.91e-03 | 200 | 161 | 5 | EFO_0000195 | |
| Disease | reticulocyte count | SLC43A2 SLC31A2 EML6 PEPD SIPA1 MAST2 BIRC6 PICALM LFNG FAT1 P2RY2 SP6 HERC1 | 4.92e-03 | 1045 | 161 | 13 | EFO_0007986 |
| Disease | free cholesterol to total lipids in medium LDL percentage | 4.98e-03 | 63 | 161 | 3 | EFO_0022283 | |
| Disease | susceptibility to hepatitis B infection measurement | 5.21e-03 | 64 | 161 | 3 | EFO_0008405 | |
| Disease | reticulocyte measurement | SLC43A2 SLC31A2 EML6 PFAS SIPA1 BIRC6 PICALM LFNG FAT1 P2RY2 SP6 AKAP13 ARMH4 | 5.24e-03 | 1053 | 161 | 13 | EFO_0010700 |
| Disease | triglycerides in small LDL measurement | 5.44e-03 | 65 | 161 | 3 | EFO_0022323 | |
| Disease | myeloid white cell count | PRUNE2 VMP1 ACAP1 TTC28 SLC31A2 EML6 PEPD DGKG MAST2 EOMES LIPA GLG1 | 5.45e-03 | 937 | 161 | 12 | EFO_0007988 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLSWVHGVMFSPDGS | 881 | O14727 | |
| PNTGSHWMRQEISFG | 356 | O95936 | |
| MGSPVHRVSLGDTWS | 1 | Q99424 | |
| GGEAHSMVWDPSGER | 396 | Q9NRG9 | |
| CMSASPGGAHSNLTW | 221 | Q6ZSZ5 | |
| NMSSVPWEGSAAAAV | 11 | A0A0U1RQF7 | |
| SDHPDVAWDLMASGF | 521 | Q8TER5 | |
| GDAVSDWSPMHEAAI | 31 | Q96DX5 | |
| ASGADSKDWLAGPHM | 1671 | Q6UB99 | |
| SHIMKDWLGGSEVNP | 3696 | Q9NR09 | |
| EAMAIGGHWSPSLDG | 496 | Q8IX12 | |
| AQVSHEGMEGGQPWT | 346 | Q86TY3 | |
| WGPGKNAASDAEMNH | 1566 | Q12802 | |
| SADIQSKGHLPSGMW | 206 | A8MVX0 | |
| QDGTAPLWIASQMGH | 176 | Q8N6D5 | |
| WGSRNHSSGMDAVFP | 216 | Q96SM3 | |
| NIINGADWHTVPGSM | 561 | Q96SM3 | |
| GDGASITWNHLDQMP | 356 | Q02928 | |
| WGGEPRAHAMAQVDA | 446 | P49753 | |
| PTMADALAHGADVNW | 586 | Q15027 | |
| SQASGPEFSDAHMTW | 61 | Q5T7M4 | |
| NHTDEEGFTPLMWAA | 176 | Q9H9E1 | |
| NWTMGLPTDNGHDSD | 346 | O94985 | |
| PVEGSETMTLGTWHH | 336 | Q96M86 | |
| HIMSGEWVKGRNPSD | 411 | Q8TE56 | |
| SWSSDSGRPKNMGTH | 721 | Q96QP1 | |
| SAMHSGDLVDSKTWG | 26 | Q7Z5Q5 | |
| WFESSLSHMKPGEEG | 941 | Q7Z5J4 | |
| PGLFSMWAHNGEVRT | 611 | Q9Y5E4 | |
| MAAATGPSFWLGNET | 1 | P12955 | |
| MAPTGHSTCNVESWG | 836 | Q9H0B3 | |
| GSAPGWDERTVSEMH | 696 | O75747 | |
| GEHGDSSVPVWSGMN | 191 | P00338 | |
| IMWLEAHDPDLGQSG | 946 | Q14517 | |
| SLLADWLEGHGMNPA | 776 | Q13164 | |
| WLEGHGMNPADIESL | 781 | Q13164 | |
| EMLWVGSHGGHATSF | 86 | Q504Q3 | |
| HPAEEGDFWAESSML | 566 | Q6Y2X3 | |
| PWDFDHLGPSASSEM | 81 | O60309 | |
| PWASGGHFMNTAERI | 271 | Q8NES3 | |
| HWGAWMPSSISAFEG | 21 | P20916 | |
| QNAHFSTMEWPIDGG | 411 | Q6P1M3 | |
| PWDFDHLGPSASSEM | 81 | A6NM11 | |
| PWDFDHLGPSASSEM | 81 | A6NMS7 | |
| KHAPMGTCWGDISEN | 161 | Q05BQ5 | |
| VGGTAEPGHEEVSWM | 61 | Q8N370 | |
| GPMHSQLESLSDSWA | 1546 | Q15751 | |
| NATGHVESMAWTTPD | 296 | Q9NQG7 | |
| LWMTALTAAGESSHG | 596 | Q99665 | |
| HDSTGMHASWFLGSV | 756 | Q8IVV2 | |
| MFNGSIAWHSEVGLP | 226 | Q5VW00 | |
| VPQDSDGGGWMEISH | 241 | Q9UK22 | |
| VLVSGADNGTMHLWD | 426 | O43660 | |
| SAAAMWPGTDVPIHD | 131 | Q9Y6X5 | |
| TNQRAGHTSGAAMWP | 126 | Q9UJA9 | |
| SEHNEPWFMRLNSTG | 61 | Q8TB36 | |
| AVGGSTHTATAAMWA | 571 | Q8TAT6 | |
| GSAAWMAPEVFEGSN | 191 | O43318 | |
| NIPSMHGGSNLWGDT | 601 | P23743 | |
| MHTVATSGPNASWGA | 1 | Q969F8 | |
| DHISDGAWDPEGEGM | 71 | A0A1B0GTW7 | |
| PANAHFIAWTGRGME | 381 | P41161 | |
| VSGWNPTSATGNHMT | 166 | Q6PEW0 | |
| MAPKPGAEWSTALSH | 1 | Q6ZMK1 | |
| MAAASEPVDSGALWG | 1 | Q9BR09 | |
| MAADLGPWNDTINGT | 1 | P41231 | |
| SGAPAAGSDQVHSWM | 16 | Q9NUU6 | |
| MSSTQGNGEHWKSLE | 1 | O00750 | |
| HESASDPAMWTVGGK | 2761 | Q5VST9 | |
| SHTVTLSWAAPMSDG | 4536 | Q5VST9 | |
| SLGSESEVGWTHMEA | 411 | Q9UHM6 | |
| QSLMKPAWSDAAHGD | 511 | Q9NZ94 | |
| CQSEMKPSWADSAHG | 476 | Q8NFZ3 | |
| SGEVMQHAWVEGNSS | 331 | P49619 | |
| HTHGWNETSEFMPQG | 576 | Q92896 | |
| DASSSWGPQMSASVH | 1456 | P04114 | |
| PDVSDGSPMWGHQTA | 116 | Q3L8U1 | |
| GSPMWGHQTATTISN | 121 | Q3L8U1 | |
| AGAFDDHGLPWMSDT | 296 | Q9P0U4 | |
| DSTMDHWAEGSPQPF | 3876 | Q4G0P3 | |
| SSNPASGVAGDVAMW | 446 | Q8IZ08 | |
| GHWTNVTPMATKRSG | 451 | Q53G59 | |
| MEESWEAAPGGQAGA | 1 | A4D1S0 | |
| WSGLHDAMFTSEIGS | 221 | A6NNT2 | |
| DFWSVHSPAGMALSV | 16 | O15432 | |
| GDGASITWNHLDQMP | 356 | Q5TCH4 | |
| MFGGHDTTASGLSWV | 326 | P98187 | |
| MFGGHDTTASGLSWV | 326 | Q9HCS2 | |
| MTWSATARGAHQPDN | 1 | Q3MIR4 | |
| ENIPGGVMRGAEWHS | 1146 | O75976 | |
| MEWGADPNHAARTVG | 211 | Q68DC2 | |
| MVWHVEDGGPASEAG | 1136 | Q6P0Q8 | |
| VDAGSGSSSQMWQPL | 121 | P11245 | |
| MDHLGASLWPQVGSL | 1 | P19235 | |
| HNMSGPNSSSEWSIE | 81 | Q7Z589 | |
| MEGEIWGLATHPSKD | 1686 | Q6ZMW3 | |
| TQTWMETGCGPHGVT | 21 | Q1T7F1 | |
| SGAMTPDHWIKRGTA | 4406 | Q9P225 | |
| GINNPGATWAELTSM | 1556 | Q58EX2 | |
| CQSEMKPSWADSAHG | 476 | Q8N0W4 | |
| VEASSPWSGSAVGMA | 116 | P20264 | |
| LQAGHGEWTDDMAPA | 346 | Q96AX9 | |
| HLGWSAMAPSGLTAA | 171 | Q9BUB5 | |
| VATNAFHSPRWGGIM | 346 | Q96S52 | |
| SMWPQTLGHLINSGT | 296 | Q9H720 | |
| QITWHSDLGGMPNTS | 176 | P15151 | |
| WVVAMAAGPGTHLSL | 141 | Q8TDU9 | |
| WQNSLGMHPGQVETS | 231 | Q4G112 | |
| SHMAEFLQTGGDPEW | 131 | P58004 | |
| FQHAMGGVPAWAETT | 186 | Q9Y5J1 | |
| HSPGAMFEWGSQRLE | 226 | Q9GZN7 | |
| QPGGEHMNSWAKAAS | 376 | Q9HCJ0 | |
| SGWGEMPNVHSKTEN | 801 | Q9HCJ0 | |
| VEVPSMASSWGGPHF | 1296 | Q9UQ35 | |
| SPAQDQSWMFLGHSE | 2626 | Q8WUY3 | |
| QSWMFLGHSEVGDPS | 2631 | Q8WUY3 | |
| DHISWHLLGMSSGPE | 251 | P12259 | |
| DATEAGSGWHEMGLL | 151 | Q16647 | |
| ASGNMHNSWITTGED | 181 | Q86SQ7 | |
| SVLSGAGMHFPWLQT | 21 | Q15573 | |
| WTGHGPSMEDSSAVL | 1081 | Q92540 | |
| AAASNQLGSWPDGML | 1001 | Q9Y6Q9 | |
| EEGGWTPLHNAVQMS | 56 | Q05823 | |
| WDLTTAMDGLGQAPA | 576 | Q8TBC3 | |
| FDWAPRSQGMGSHSE | 126 | Q96FS4 | |
| IVGSAWSGAPMIDNS | 611 | Q5C9Z4 | |
| NGHTAPVRGLMWNTE | 606 | Q8IZU2 | |
| MEPGGSENAAALWIS | 1 | Q66K80 | |
| GTSWMDLPHTQGALT | 126 | Q3SY56 | |
| GHPGSDSARASMADW | 321 | Q9H093 | |
| SGGSISWNDFVHEML | 161 | Q9UQ90 | |
| MSGLECQAWDSQSPH | 201 | P00747 | |
| PEEKVTWDGHSGSMA | 496 | Q15459 | |
| MVHQATTSSWVAGSG | 251 | Q92537 | |
| QAAWDPTGHSMAAAP | 1056 | Q9NZP6 | |
| GLNSSGEELNHWTEM | 156 | Q58G82 | |
| TWGNHTPIFRDAGMQ | 161 | P00505 | |
| SMAAWFPDGIHTDSS | 476 | P51788 | |
| HPMSTASQVASTWGD | 406 | Q13492 | |
| HGGAVSPQSLSEWRM | 321 | O00562 | |
| SGSSDHSVIMWDIGG | 216 | Q96P53 | |
| LLEGNPDTHSWEMVG | 86 | Q14157 | |
| AAPMWLNGTHPSSDE | 226 | P07911 | |
| AAVTAVAWAPDGSMA | 2281 | Q99973 | |
| VAWAPDGSMAVSGNQ | 2286 | Q99973 | |
| PDGSTHFPSWEMAAN | 81 | P57738 | |
| GTWGSATVFMPHVTE | 566 | P41226 | |
| AQMHGLPGSQDWTAL | 736 | P41226 | |
| TWMESGVSENAVSGH | 201 | Q9GZZ9 | |
| GMEGAVLPVWSAHGE | 1221 | O15067 | |
| MAADVSWHSLGLEQG | 126 | P80108 | |
| ATMSQPLAGSEDGAW | 1776 | Q6ZS81 | |
| NGPTLSHMDSWDNRD | 1506 | O15015 | |
| DADLSGMTWSHGLSV | 311 | P48594 | |
| MGWLANGSTAHPVVF | 2256 | Q9NY15 | |
| WRLGHGEPTFMNSTV | 1071 | Q9NNW5 | |
| TAAEPGGRTMSDHWQ | 366 | Q96BW9 | |
| GSMGQLPHTVSWFTH | 201 | P36402 | |
| DTMAWPSGIELASFG | 951 | O60290 | |
| HPSNWAGFMLIGSDV | 1701 | Q96AY4 | |
| PDVHWMGTGALRSAQ | 151 | P59923 | |
| MAVAGAVSGEPLVHW | 1 | Q15650 | |
| QWSTSPFSGLLHMGQ | 561 | Q8NHP8 | |
| VGDDLFHWQATIMGP | 26 | Q9Y2X8 | |
| IQELMEAGGWHPSSS | 516 | Q2TAA8 | |
| SRDWHGVPGQVDAAM | 336 | P04004 | |
| PNTGAHWMRQEVSFG | 226 | Q9UL17 | |
| ALMEHSNCSSEPGFW | 986 | Q8TD43 | |
| MSDLQAAEGPGSWSP | 1 | Q6PL24 | |
| HTDAFQDWGPGSMAH | 271 | P78423 | |
| VGDDLFHWQATIMGP | 26 | P51668 | |
| HKSEMGTPQGENWLS | 351 | Q96GC9 | |
| PGMDHSEANSLGVTW | 1016 | P82987 | |
| KDMLVPTAVWSGGHD | 331 | P38571 | |
| GREPAAHQRGSSSWM | 276 | Q5JTD7 | |
| TMHWVGPDDRLVGNS | 311 | Q6PJG9 | |
| LMWLSSHQEGPRSSG | 746 | Q8N9H8 | |
| GIGWMPNDSVSVNHA | 4121 | P20929 |